Sonoma Pharmaceuticals
SNOA
#10573
Rank
A$5.77 M
Marketcap
A$3.34
Share price
-5.35%
Change (1 day)
-3.64%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -A$4.89 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$16.93 Million. In 2024 the company made an earning of -A$6.48 Million a decrease over its 2023 earnings that were of -A$6.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.89 Million-24.61%
2024 -A$6.48 Million0.54%
2023 -A$6.45 Million-31.5%
2022 -A$9.41 Million16.86%
2021 -A$8.05 Million194.32%
2020 -A$2.74 Million-58.76%
2019 -A$6.63 Million-65.66%
2018 -A$19.31 Million4.84%
2017 -A$18.42 Million-2.17%
2016 -A$18.83 Million32.12%
2015 -A$14.25 Million-307.74%
2014 A$6.85 M-197.5%
2013 -A$7.04 Million
2010 -A$11 Million-14.02%
2009 -A$12.79 Million-57.28%
2008 -A$29.93 Million-8.03%
2007 -A$32.54 Million3.85%
2006 -A$31.33 Million39.31%
2005 -A$22.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.35 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA